Click here to search courses using NAPNAP's previous Course Catalog layout.

Event date
  • FREE for Members
  • Pharmacology CE
  • Contact hours
1.0 contact hour of which 1.25 contain pharmacology content. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is $10. Clostridioides difficile infection (CDI) is a major public health concern for pediatric and adult patients. The management of pediatric CDI poses a challenge to healthcare providers due to lack of strong randomized controlled trials to guide pharmacological management. Additionally, recent updates to CDI guidelines recommend oral vancomycin over metronidazole for the management of CDI in adults, leaving questions regarding how to best manage pediatric patients. This continuing education pharmacotherapy review describes available evidence for the safety and efficacy of medications used in the treatment and management of pediatric CDI and aims to clarify discrepancies between pediatric and adult recommendations.